10-Q Filing

IOVANCE BIOTHERAPEUTICS, INC. CIK: 1425205 Q1 2018

Filing Information

Form Type	10-Q
Accession Number	`0001144204-18-026764`
Period End Date	20180331
Filing Date	20180510
Fiscal Year	2018
Fiscal Period	Q1
XBRL Instance	iova-20180331.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 40 Income Statement 18 Cash Flow Statement 50 Comprehensive Income 6

Balance Sheet 40 line items

Line Item	Tag	Value	Unit	Period
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$107.10M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$145.37M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$297.08M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$106.72M	USD	Point-in-time
Prepaid expenses and other assets	`PrepaidExpenseAndOtherAssetsCurrent`	$3.92M	USD	Point-in-time
Prepaid expenses and other assets	`PrepaidExpenseAndOtherAssetsCurrent`	$5.64M	USD	Point-in-time
Total Current Assets	`AssetsCurrent`	$302.73M	USD	Point-in-time
Total Current Assets	`AssetsCurrent`	$149.29M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$2.25M	USD	Point-in-time
Common Stock, Par or Stated Value Per Share	`CommonStockParOrStatedValuePerShare`	-	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$2.45M	USD	Point-in-time
Common Stock, Par or Stated Value Per Share	`CommonStockParOrStatedValuePerShare`	-	USD	Point-in-time
Long-term assets	`OtherAssetsNoncurrent`	$3.63M	USD	Point-in-time
Common Stock, Shares Authorized	`CommonStockSharesAuthorized`	150.00M	shares	Point-in-time
Common Stock, Shares Authorized	`CommonStockSharesAuthorized`	150.00M	shares	Point-in-time
Long-term assets	`OtherAssetsNoncurrent`	$2.27M	USD	Point-in-time
Total Assets	`Assets`	$155.37M	USD	Point-in-time
Total Assets	`Assets`	$307.25M	USD	Point-in-time
Common Stock, Shares, Issued	`CommonStockSharesIssued`	89.62M	shares	Point-in-time
Common Stock, Shares, Issued	`CommonStockSharesIssued`	73.16M	shares	Point-in-time
Common Stock, Shares, Outstanding	`CommonStockSharesOutstanding`	73.16M	shares	Point-in-time
Common Stock, Shares, Outstanding	`CommonStockSharesOutstanding`	89.62M	shares	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$6.58M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$1.23M	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$8.11M	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$8.66M	USD	Point-in-time
Total Current Liabilities	`LiabilitiesCurrent`	$14.69M	USD	Point-in-time
Total Current Liabilities	`LiabilitiesCurrent`	$9.89M	USD	Point-in-time
Commitments and contingencies (Note 9)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies (Note 9)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Common stock, $0.000041666 par value; 150,000,000 shares authorized, 89,615,417 and 73,164,914 shares issued and outstanding as of March 31, 2018 and December 31, 2017, respectively	`CommonStockValue`	$3.00K	USD	Point-in-time
Common stock, $0.000041666 par value; 150,000,000 shares authorized, 89,615,417 and 73,164,914 shares issued and outstanding as of March 31, 2018 and December 31, 2017, respectively	`CommonStockValue`	$3.00K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$394.65M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$568.24M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-275.69M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-249.18M	USD	Point-in-time
Total Stockholders Equity	`StockholdersEquity`	$292.56M	USD	Point-in-time
Total Stockholders Equity	`StockholdersEquity`	$145.48M	USD	Point-in-time
Total Liabilities and Stockholders Equity	`LiabilitiesAndStockholdersEquity`	$155.37M	USD	Point-in-time
Total Liabilities and Stockholders Equity	`LiabilitiesAndStockholdersEquity`	$307.25M	USD	Point-in-time

Income Statement 18 line items

Line Item	Tag	Value	Unit	Period
Revenues	`Revenues`	-	USD	1 Quarter
Revenues	`Revenues`	-	USD	1 Quarter
Research and development expenses	`ResearchAndDevelopmentExpense`	$15.59M	USD	1 Quarter
Research and development expenses	`ResearchAndDevelopmentExpense`	$19.91M	USD	1 Quarter
General and administrative expenses	`GeneralAndAdministrativeExpense`	$6.96M	USD	1 Quarter
General and administrative expenses	`GeneralAndAdministrativeExpense`	$5.29M	USD	1 Quarter
Total costs and expenses	`OperatingExpenses`	$26.88M	USD	1 Quarter
Total costs and expenses	`OperatingExpenses`	$20.88M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-20.88M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-26.88M	USD	1 Quarter
Interest income	`InvestmentIncomeInterest`	$198.00K	USD	1 Quarter
Interest income	`InvestmentIncomeInterest`	$362.00K	USD	1 Quarter
Net Loss	`NetIncomeLoss`	$-26.52M	USD	1 Quarter
Net Loss	`NetIncomeLoss`	$-20.68M	USD	1 Quarter
Net Loss Per Common Share, Basic and Diluted	`EarningsPerShareBasicAndDiluted`	$-0.31	USD	1 Quarter
Net Loss Per Common Share, Basic and Diluted	`EarningsPerShareBasicAndDiluted`	$-0.33	USD	1 Quarter
Weighted-Average Common Shares Outstanding, Basic and Diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	84,350.00	shares	1 Quarter
Weighted-Average Common Shares Outstanding, Basic and Diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	62,286.00	shares	1 Quarter

Cash Flow Statement 50 line items

Line Item	Tag	Value	Unit	Period
Net loss	`NetIncomeLoss`	$-26.52M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-20.68M	USD	1 Quarter
Depreciation and amortization	`DepreciationAndAmortization`	$228.00K	USD	1 Quarter
Depreciation and amortization	`DepreciationAndAmortization`	$221.00K	USD	1 Quarter
Loss on disposal of assets	`GainLossOnDispositionOfAssets`	$-9.00K	USD	1 Quarter
Loss on disposal of assets	`GainLossOnDispositionOfAssets`	-	USD	1 Quarter
Amortization of discount on investments	`AmortizationOfDebtDiscountPremium`	$28.00K	USD	1 Quarter
Amortization of discount on investments	`AmortizationOfDebtDiscountPremium`	-	USD	1 Quarter
Stock-based compensation expense	`ShareBasedCompensation`	$3.30M	USD	1 Quarter
Stock-based compensation expense	`ShareBasedCompensation`	$4.10M	USD	1 Quarter
Prepaid expenses and other assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$2.35M	USD	1 Quarter
Prepaid expenses and other assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$368.00K	USD	1 Quarter
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$1.47M	USD	1 Quarter
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$5.24M	USD	1 Quarter
Accrued expenses	`IncreaseDecreaseInAccruedLiabilities`	$-546.00K	USD	1 Quarter
Accrued expenses	`IncreaseDecreaseInAccruedLiabilities`	$-776.00K	USD	1 Quarter
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-18.80M	USD	1 Quarter
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-17.85M	USD	1 Quarter
Maturities of short- term investments	`ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities`	$19.60M	USD	1 Quarter
Maturities of short- term investments	`ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities`	-	USD	1 Quarter
Purchase of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$22.00K	USD	1 Quarter
Purchase of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$798.00K	USD	1 Quarter
Net cash (used in) provided by investing activities	`NetCashProvidedByUsedInInvestingActivities`	$18.80M	USD	1 Quarter
Net cash (used in) provided by investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-22.00K	USD	1 Quarter
Tax payments related to shares withheld for vested restricted stock awards	`PaymentsRelatedToTaxWithholdingForShareBasedCompensation`	$62.00K	USD	1 Quarter
Tax payments related to shares withheld for vested restricted stock awards	`PaymentsRelatedToTaxWithholdingForShareBasedCompensation`	$4.00K	USD	1 Quarter
Proceeds from the issuance of common stock upon exercise of warrants	`ProceedsFromWarrantExercises`	$156.00K	USD	1 Quarter
Proceeds from the issuance of common stock upon exercise of warrants	`ProceedsFromWarrantExercises`	$1.83M	USD	1 Quarter
Proceeds from the issuance of common stock upon exercise of options	`ProceedsFromStockOptionsExercised`	$231.00K	USD	1 Quarter
Proceeds from the issuance of common stock upon exercise of options	`ProceedsFromStockOptionsExercised`	$5.63M	USD	1 Quarter
Proceeds from the issuance of common stock, net	`ProceedsFromIssuanceOfCommonStock`	$162.19M	USD	1 Quarter
Proceeds from the issuance of common stock, net	`ProceedsFromIssuanceOfCommonStock`	-	USD	1 Quarter
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$383.00K	USD	1 Quarter
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$169.58M	USD	1 Quarter
Net increase in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$382.00K	USD	1 Quarter
Net increase in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$151.71M	USD	1 Quarter
Cash and Cash Equivalents, Beginning of Period	`CashAndCashEquivalentsAtCarryingValue`	$107.10M	USD	Point-in-time
Cash and Cash Equivalents, Beginning of Period	`CashAndCashEquivalentsAtCarryingValue`	$145.37M	USD	Point-in-time
Cash and Cash Equivalents, Beginning of Period	`CashAndCashEquivalentsAtCarryingValue`	$297.08M	USD	Point-in-time
Cash and Cash Equivalents, Beginning of Period	`CashAndCashEquivalentsAtCarryingValue`	$106.72M	USD	Point-in-time
Cash and Cash Equivalents, End of Period	`CashAndCashEquivalentsAtCarryingValue`	$107.10M	USD	Point-in-time
Cash and Cash Equivalents, End of Period	`CashAndCashEquivalentsAtCarryingValue`	$145.37M	USD	Point-in-time
Cash and Cash Equivalents, End of Period	`CashAndCashEquivalentsAtCarryingValue`	$297.08M	USD	Point-in-time
Cash and Cash Equivalents, End of Period	`CashAndCashEquivalentsAtCarryingValue`	$106.72M	USD	Point-in-time
Unrealized loss on short-term investments	`UnrealizedGainLossOnShorttermInvestments`	-	USD	1 Quarter
Unrealized loss on short-term investments	`UnrealizedGainLossOnShorttermInvestments`	$-27.00K	USD	1 Quarter
Acquisitions of property and equipment under accounts payable	`LeaseholdImprovementsPaidByLandlord`	$-155.00K	USD	1 Quarter
Acquisitions of property and equipment under accounts payable	`LeaseholdImprovementsPaidByLandlord`	$-12.00K	USD	1 Quarter
Offering costs included in accounts payable	`OfferingCostsUnderAccountsPayableAndAccruedExpenses`	$-93.00K	USD	1 Quarter
Offering costs included in accounts payable	`OfferingCostsUnderAccountsPayableAndAccruedExpenses`	-	USD	1 Quarter

Comprehensive Income 6 line items

Line Item	Tag	Value	Unit	Period
Net Loss	`NetIncomeLoss`	$-26.52M	USD	1 Quarter
Net Loss	`NetIncomeLoss`	$-20.68M	USD	1 Quarter
Unrealized loss on short-term investments	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-27.00K	USD	1 Quarter
Unrealized loss on short-term investments	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	-	USD	1 Quarter
Comprehensive Loss	`ComprehensiveIncomeNetOfTax`	$-20.71M	USD	1 Quarter
Comprehensive Loss	`ComprehensiveIncomeNetOfTax`	$-26.52M	USD	1 Quarter

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.